|
NightstaRx Appoints Ophthalmology Industry Veteran Scott Whitcup to Board of Directors
Business Wire (press release) BOSTON–(BUSINESS WIRE)–NightstaRx Ltd (“Nightstar”), a biopharmaceutical company specializing in developing gene therapies for inherited retinal dystrophies, today announced the appointment of Scott M. Whitcup, M.D. to its board of directors. |
May 02, 2017 at 04:31PM
from
No comments:
Post a Comment